Ethylene, refrigerated liquid (cryogenic liquid) appears as a pressurized liquid when shipped below 50°F. Colorless with a sweet odor and taste. Vapors arising from the boiling liquid are lighter than air. Easily ignited. Not toxic but is a simple asphyxiant. Under prolonged exposure to fire or intense heat the containers may rupture violently and rocket. Used as an anesthetic, a refrigerant, and to make other chemicals.
颜色/状态:
Colorless gas
气味:
Sweet
味道:
Tasteless
溶解度:
1 volume dissolves in about 4 volumes water at 0 °C, in about 9 volumes water at 25 °C, in about 0.5 volumes alcohol at 25 °C, in about 0.05 volumes ether at 15.5 °C
蒸汽密度:
0.98 (Air = 1)
蒸汽压力:
5.21X10+4 mm Hg at 25 °C /Extrapolated/
亨利常数:
Henry's Law constant = 0.228 atm-cu m/mole at 25 °C
Male CBA mice exposed to air containing 19.6 mg/cu m ... (14)C-labeled ethylene metabolized ethylene to ethylene oxide, which binds to cellular proteins.
Four male CBA mice (average body weight, 31 g) were exposed together for 1 hr in a closed glass chamber (5.6 L) to (14)C-ethylene (22 mCi/mmol) in air at 17 ppm x hr (22.3 (mg/cu m) x hr, equivalent to about 1 mg/kg bw). Blood and organs from two mice were pooled 4 hr after the end of exposure. Radioactivity was about the same in kidney (0.16 uCi/g wet weight) and liver (0.14 uCi/g) but lower in testis (0.035 uCi/g), brain (0.02 uCi/g) and Hb (0.0094 uCi/g Hb). Urine was collected from the two other mice during 48 hr, and blood was collected after 21 days. 5-(2-Hydroxyethyl)cysteine was identified as a metabolite of ethylene in urine (3% of (14)C in urine) by thin-layer chromatography. The radioactivity in Hb was 0.011 uCi/g Hb. These data, together with those on specific hydroxyethyl derivatives at amino acid residues of Hb, indicated that ethylene was metabolized to ethylene oxide.
Experiments proved ethylene to be converted in certain species, notably mice and rats, into the carcinogenic and mutagenic ethylene oxide. Carcinogenic effect of ethylene of endogenous origin is suggested. Whether such an effect is possible with oral administration of ethylene is not clear.
IDENTIFICATION AND USE: Ethylene is a colorless gas. It is used for oxyethylene welding and cutting metals, as well as in the manufacture of alcohol, mustard gas, and many other organics. It is also used in manufacture of ethylene oxide (for plastics), polythene, polystyrene and other plastics. Ethylene is a plant growth regulator, which is used commercially to accelerate the ripening of various fruits. HUMAN STUDIES: Exposure to 37.5% ethylene for 15 min may result in marked memory disturbances. Humans exposed to as much as 50% ethylene in air, whereby the oxygen availability is decreased to 10%, experienced a loss of consciousness. Prolonged inhalation of 85% ethene in air is slightly toxic, whereas 94% in oxygen is fatal. Death is certain at 8% oxygen. In fatal human intoxication, ethylene affects the respiratory center of the brain and kills by suffocation. Postmortem analysis has revealed that the right side of the heart is full of blood, while the left side is empty. In workers chronically exposed, ethylene has been associated with a decrease in maximum arterial pressure, slower pulse, lengthened later period of the visual-motor response, increased thresholds of olfaction and hearing, and tension of the thermoregulatory apparatus. In eight people not occupationally exposed to ethylene, the DNA adduct 7-(2-hydroxyethyl)guanine was detected at a background level in peripheral lymphocytes. ANIMAL STUDIES: Mice were dosed by gavage with 3.75 mg/kg bw ethylene for 4 months. The treated animals displayed no changes in behavior or in body weight gain and oxygen consumption. Gross pathology examination revealed no changes in the relative weights or in the histological structure of the visceral organs. Inhalation exposure to 600,000 ppm continuously for 90 days in rats caused reduced food uptake and activity, peripheral leucopenia, decreased thrombocyte and erythrocyte count, and decrease in bone marrow cellularity. One-day-old and adult rats continuously exposed to 3 mg/cu m per day for 90 days exhibited hypertension, disruption of the subordination chronaxy, and decreased cholinesterase activity. Experiments proved ethylene to be metabolized in certain species, notably mice and rats, into the carcinogenic and mutagenic ethylene oxide. Administration of ethylene by head-only exposure revealed no potential for adverse reproductive effects in the rat. Ethylene was not found to be mutagenic with or without metabolic activation in Salmonella typhimurium strains TA98, TA1537, TA100, or TA1535. Rats and mice exposed 6 hr/day 5 days/week for 4 weeks to 40-3000 ppm ethylene did not have a significant increase in the frequency of micronucleated polychromatic erythrocytes in the bone marrow, when compared to the control group.
Evaluation: There is inadequate evidence in humans for the carcinogenicity of ethylene. There is inadequate evidence in experimental animals for the carcinogenicity of ethylene. Overall evaluation: Ethylene is not classifiable as to its carcinogenicity to humans (Group 3).
来源:Hazardous Substances Data Bank (HSDB)
毒理性
致癌性证据
A4;不可归类为人类致癌物。
A4; Not classifiable as a human carcinogen.
来源:Hazardous Substances Data Bank (HSDB)
毒理性
致癌物分类
国际癌症研究机构致癌物:乙烯
IARC Carcinogenic Agent:Ethylene
来源:International Agency for Research on Cancer (IARC)
毒理性
致癌物分类
国际癌症研究机构(IARC)致癌物分类:第3组:无法归类其对人类致癌性
IARC Carcinogenic Classes:Group 3: Not classifiable as to its carcinogenicity to humans
来源:International Agency for Research on Cancer (IARC)
When equilibrium is reached, the rate of transfer of gas molecules from the alveolar space to blood equals the rate of removal by blood from the alveolar space. For example, ... ethylene has a low (0.14) blood/gas phase solubility ratio. For a substance with a low solubility ratio such as ethylene, only a small percentage of the total gas is removed by blood during each circulation because blood is soon saturated with the gas.
来源:Hazardous Substances Data Bank (HSDB)
吸收、分配和排泄
乙烯在2/8受试者的呼出气中的浓度为0.91和120微克/小时。
Ethylene has been determined in expired air of 2/8 human subjects at rate of 0.91 and 120 ug/hr.
The inhalation pharmacokinetics of ethylene have been investigated in human volunteers at atmospheric concentrations of up to 50 ppm (157.5 mg/cu m) by gas uptake in a closed spirometer system. The uptake, exhalation and metabolism of ethylene can be described by first-order kinetics. Uptake of ethylene into the body is low. Clearance due to uptake, which reflects the transfer rate of ethylene from the atmosphere into the body, was 25 L/hr for a man of 70 kg. This value represents only 5.6% of the experimentally obtained alveolar ventilation rate of 150 L/hr. The majority (94.4%) of ethylene inhaled into the lungs is exhaled again without becoming systemically available via the blood stream. Maximal accumulation of ethylene in the same man, determined as the thermodynamic partition coefficient whole body:air was 0.53. The concentration ratio at steady state was even smaller (0.33), owing to metabolic elimination. Clearance due to metabolism, in relation to the concentration in the atmosphere, was calculated to be 9.3 L/hr for a man of 70 kg. This indicates that at steady state about 36% of systemically available ethylene is eliminated metabolically and 64% is eliminated by exhalation as the unchanged substance, as can be calculated from the values of clearance of uptake and of clearance of metabolism. The biological half-life of ethylene was 0.65 hr. The alveolar retention of ethylene at steady state was calculated to be 2%. From theoretical considerations of the lung uptake of gases and vapors, it can be deduced that the low uptake rate of ethylene is due to its low solubility in blood: Ostwald's solubility coefficient for human blood at 37 °C, 0.15.
Compositions for Treatment of Cystic Fibrosis and Other Chronic Diseases
申请人:Vertex Pharmaceuticals Incorporated
公开号:US20150231142A1
公开(公告)日:2015-08-20
The present invention relates to pharmaceutical compositions comprising an inhibitor of epithelial sodium channel activity in combination with at least one ABC Transporter modulator compound of Formula A, Formula B, Formula C, or Formula D. The invention also relates to pharmaceutical formulations thereof, and to methods of using such compositions in the treatment of CFTR mediated diseases, particularly cystic fibrosis using the pharmaceutical combination compositions.
Fe and Co Complexes of Rigidly Planar Phosphino-Quinoline-Pyridine Ligands for Catalytic Hydrosilylation and Dehydrogenative Silylation
作者:Debashis Basu、Ryan Gilbert-Wilson、Danielle L. Gray、Thomas B. Rauchfuss、Aswini K. Dash
DOI:10.1021/acs.organomet.8b00416
日期:2018.8.27
of simple and complex 1-alkenes with a variety of hydrosilanes. Catalystsderivedfrom MesNQpy exhibited low activity. Fe-RPQpy derivedcatalysts favor hydrosilylation, whereas Co-RPQpy based catalysts favor dehydrogenative silylation. Catalystsderivedfrom CoX2(iPrPQpy) convert hydrosilanes and ethylene to vinylsilanes. Related experiments were conducted on propylene to give propenylsilanes.
Model Guided Development of a Simple Catalytic Method for the Synthesis of Unsymmetrical Stilbenes by Sequential Heck Reactions of Aryl Bromides with Ethylene
作者:Helen Barlow、Jonas Y. Buser、Hendrik Glauninger、Carla V. Luciani、Joseph R. Martinelli、Niall Oram、Nichole Thompson‐Van Hook、Jeffery Richardson
DOI:10.1002/adsc.201800167
日期:2018.7.16
moieties, but methods for their preparation typically possess numerous inefficiencies. Presented here is a methodology for the two‐step, one pot preparation of unsymmetrical stilbenes via sequential Heck reactions. The first Heck reaction with ethylene gas was analysed as a function of temperature and pressure for electronically differentiated naphthyl bromides and model‐aided reaction optimization was utilized
Synthesis of styrene and stilbene derivatives by the palladium-catalysed arylation of ethylene with aroyl chlorides
作者:Alwyn Spencer
DOI:10.1016/s0022-328x(00)98836-3
日期:1983.5
with aroyl chlorides, catalysed by palladium(II) acetate, leads to styrene and stilbene derivatives. By appropriate choice of reaction conditions, particularly the ethylene pressure, the reaction can be made to produce either styrene or stilbene derivatives selectively. The reaction tolerates those common substituents which do not react with aroyl chlorides. Only trans-stilbene derivatives are formed